Abbott Laboratories (ABT) Long-Term Investments (2009 - 2026)

Abbott Laboratories' Long-Term Investments history runs 18 years deep, the most recent figure standing at $1.1 billion for Q1 2026.

• In Q1 2026, Long-Term Investments rose 20.18% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $1.1 billion (up 20.18% YoY), while the FY2025 annual figure was $918.0 million, up 3.61% from the prior year.
• Long-Term Investments came in at $1.1 billion for Q1 2026 at Abbott Laboratories, up from $918.0 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $1.1 billion in Q1 2026 to a low of $734.0 million in Q2 2022.
• A 5-year average of $853.3 million and a median of $818.0 million in 2024 frame the typical range for Long-Term Investments.
• Across the five-year window, Long-Term Investments retreated 8.82% in 2022 and climbed 20.18% in 2026, its largest moves.
• Abbott Laboratories' Long-Term Investments stood at $766.0 million in 2022, then rose by 4.31% to $799.0 million in 2023, then advanced by 10.89% to $886.0 million in 2024, then rose by 3.61% to $918.0 million in 2025, then gained by 18.74% to $1.1 billion in 2026.
• According to Business Quant data, Long-Term Investments over the past three periods registered $1.1 billion, $918.0 million, and $951.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison